AZNs Tagrisso Gets FDA Nod for Expanded Use in NSCLC
The FDA approves AstraZenecas Tagrisso for treating unresectable, stage III EGFR-mutated non-small cell lung cancer.…
81,000€
4,52%
Echtzeit-Aktienkurs ASTRAZENECA DL-,25 SP.ADR
Bid:
Ask:
Nachrichten zur ASTRAZENECA DL-,25 SP.ADR Aktie
AstraZeneca Stock Up Almost 14% in 6 Months: Time to Buy?
AZNs key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Farxiga are likely to drive sales. It has several candidates with…
Top Stock Reports for Toyota, AstraZeneca & Chubb
Todays Research Daily features new research reports on 16 major stocks, including Toyota Motor Corp. (TM), AstraZeneca PLC (AZN) and…
AstraZeneca PLC (AZN) Annual Deutsche Bank Leveraged Finance Conference (Transcript)
…
FIVE at FIVE: Another Rightmove bid; Gold hits fresh high; FTSE 100 up; More AstraZeneca woe, fuel prices fall
1. Rightmove receives third bid from genuinely disappointed REA Group This marks the third approach made by REA, following an…